» Articles » PMID: 30323037

Daptomycin Pore Formation and Stoichiometry Depend on Membrane Potential of Target Membrane

Overview
Specialty Pharmacology
Date 2018 Oct 17
PMID 30323037
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Daptomycin is a calcium-dependent lipodepsipeptide antibiotic clinically used to treat serious infections caused by Gram-positive pathogens. Its precise mode of action is somewhat controversial; the biggest issue is daptomycin pore formation, which we directly investigated here. We first performed a screening experiment using propidium iodide (PI) entry to cells and chose the optimum and therapeutically relevant conditions (10 µg/ml daptomycin and 1.25 mM CaCl) for the subsequent analyses. Using conductance measurements on planar lipid bilayers, we show that daptomycin forms nonuniform oligomeric pores with conductance ranging from 120 pS to 14 nS. The smallest conductance unit is probably a dimer; however, tetramers and pentamers occur in the membrane most frequently. Moreover, daptomycin pore-forming activity is exponentially dependent on the applied membrane voltage. We further analyzed the membrane-permeabilizing activity in cells using fluorescence methods [PI and DiSC(5)]. Daptomycin most rapidly permeabilizes cells with high initial membrane potential and dissipates it within a few minutes. Low initial membrane potential hinders daptomycin pore formation.

Citing Articles

Overexpression of diglucosyldiacylglycerol synthase leads to daptomycin resistance in .

Yamamoto R, Ishikawa K, Miyoshi Y, Furuta K, Miyoshi S, Kaito C J Bacteriol. 2024; 206(10):e0030724.

PMID: 39235960 PMC: 11500525. DOI: 10.1128/jb.00307-24.


The CRISPR effector Cam1 mediates membrane depolarization for phage defence.

Baca C, Yu Y, Rostol J, Majumder P, Patel D, Marraffini L Nature. 2024; 625(7996):797-804.

PMID: 38200316 PMC: 10808066. DOI: 10.1038/s41586-023-06902-y.


Lipid-Centric Approaches in Combating Infectious Diseases: Antibacterials, Antifungals and Antivirals with Lipid-Associated Mechanisms of Action.

Ostroumova O, Efimova S Antibiotics (Basel). 2023; 12(12).

PMID: 38136750 PMC: 10741038. DOI: 10.3390/antibiotics12121716.


The Mechanism of Antimicrobial Activity of Conjugated Bile Acids against Lactic Acid Bacilli.

Chai L, Wu H, Wang X, He L, Guo C Microorganisms. 2023; 11(7).

PMID: 37512995 PMC: 10386348. DOI: 10.3390/microorganisms11071823.


LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.

Do Pham D, Mojr V, Helusova M, Mikusova G, Pohl R, Davidova E J Med Chem. 2022; 65(14):10045-10078.

PMID: 35839126 PMC: 9580004. DOI: 10.1021/acs.jmedchem.2c00684.


References
1.
Rubinchik E, Schneider T, Elliott M, Scott W, Pan J, Anklin C . Mechanism of action and limited cross-resistance of new lipopeptide MX-2401. Antimicrob Agents Chemother. 2011; 55(6):2743-54. PMC: 3101398. DOI: 10.1128/AAC.00170-11. View

2.
Taylor R, Beriashvili D, Taylor S, Palmer M . Daptomycin Pore Formation Is Restricted by Lipid Acyl Chain Composition. ACS Infect Dis. 2017; 3(11):797-801. DOI: 10.1021/acsinfecdis.7b00138. View

3.
Malinsky J, Tanner W, Opekarova M . Transmembrane voltage: Potential to induce lateral microdomains. Biochim Biophys Acta. 2016; 1861(8 Pt B):806-811. DOI: 10.1016/j.bbalip.2016.02.012. View

4.
Muraih J, Pearson A, Silverman J, Palmer M . Oligomerization of daptomycin on membranes. Biochim Biophys Acta. 2011; 1808(4):1154-60. DOI: 10.1016/j.bbamem.2011.01.001. View

5.
Taylor S, Palmer M . The action mechanism of daptomycin. Bioorg Med Chem. 2016; 24(24):6253-6268. DOI: 10.1016/j.bmc.2016.05.052. View